These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9109500)
1. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Liu C; Calogero A; Ragona G; Adamson E; Mercola D Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500 [TBL] [Abstract][Full Text] [Related]
2. Reciprocal modulation between Sp1 and Egr-1. Huang RP; Fan Y; Ni Z; Mercola D; Adamson ED J Cell Biochem; 1997 Sep; 66(4):489-99. PubMed ID: 9282327 [TBL] [Abstract][Full Text] [Related]
3. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Huang RP; Darland T; Okamura D; Mercola D; Adamson ED Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797 [TBL] [Abstract][Full Text] [Related]
4. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Huang RP; Liu C; Fan Y; Mercola D; Adamson ED Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551 [TBL] [Abstract][Full Text] [Related]
5. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497 [TBL] [Abstract][Full Text] [Related]
6. Suppression of growth and transformation and induction of apoptosis by EGR-1. Liu C; Rangnekar VM; Adamson E; Mercola D Cancer Gene Ther; 1998; 5(1):3-28. PubMed ID: 9476963 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors. Heegaard AM; Xie Z; Young MF; Nielsen KL J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591 [TBL] [Abstract][Full Text] [Related]
9. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes. Skerka C; Decker EL; Zipfel PF Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390 [TBL] [Abstract][Full Text] [Related]
10. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1. Wilder PJ; Bernadt CT; Kim JH; Rizzino A Mol Reprod Dev; 2002 Nov; 63(3):282-90. PubMed ID: 12237943 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713 [TBL] [Abstract][Full Text] [Related]
13. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells. Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103 [TBL] [Abstract][Full Text] [Related]
14. HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Sakamoto KM; Nimer SD; Rosenblatt JD; Gasson JC Oncogene; 1992 Nov; 7(11):2125-30. PubMed ID: 1359492 [TBL] [Abstract][Full Text] [Related]
15. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression and activity of the immediate-early growth response (Egr-1) gene product during cellular senescence. Meyyappan M; Wheaton K; Riabowol KT J Cell Physiol; 1999 Apr; 179(1):29-39. PubMed ID: 10082129 [TBL] [Abstract][Full Text] [Related]
17. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Sakamoto Y; Yoshida M; Semba K; Hunter T Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517 [TBL] [Abstract][Full Text] [Related]
19. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Liu C; Adamson E; Mercola D Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11831-6. PubMed ID: 8876223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]